X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39) 39
humans (33) 33
pharmacology & pharmacy (25) 25
pharmacokinetics (15) 15
male (13) 13
analysis (12) 12
dabigatran (12) 12
adult (10) 10
rivaroxaban (9) 9
apixaban (8) 8
female (8) 8
aged (7) 7
anticoagulants (7) 7
anticoagulants - pharmacokinetics (7) 7
drug interactions (7) 7
models, biological (7) 7
p-glycoprotein (7) 7
permeability (7) 7
drugs (6) 6
hematology (6) 6
reproducibility of results (6) 6
tandem mass spectrometry - methods (6) 6
thrombin (6) 6
venous thromboembolism (6) 6
young adult (6) 6
administration, oral (5) 5
anticoagulants - administration & dosage (5) 5
chemistry, analytical (5) 5
cross-over studies (5) 5
expression (5) 5
factor xa inhibitor (5) 5
life sciences (5) 5
middle aged (5) 5
population pharmacokinetics (5) 5
abc transporters (4) 4
anticoagulants - blood (4) 4
direct oral anticoagulants (4) 4
edoxaban (4) 4
france (4) 4
mass spectrometry (4) 4
medical research (4) 4
medicine, experimental (4) 4
peripheral vascular disease (4) 4
pharmacology/toxicology (4) 4
prevention (4) 4
proteins (4) 4
pulmonary hypertension (4) 4
reference standards (4) 4
replacement (4) 4
respiratory system (4) 4
surgery (4) 4
warfarin (4) 4
anti-xa (3) 3
anticoagulants - adverse effects (3) 3
anticoagulants - pharmacology (3) 3
anticoagulants - therapeutic use (3) 3
antithrombins - blood (3) 3
area under curve (3) 3
arterial-hypertension (3) 3
atp-binding cassette, sub-family b, member 1 - metabolism (3) 3
atrial-fibrillation (3) 3
bioavailability (3) 3
biomedicine (3) 3
blood coagulation tests (3) 3
blood coagulation, fibrinolysis and cellular haemostasis (3) 3
blood-brain barrier (3) 3
body weight (3) 3
caco-2 cells (3) 3
cell-line (3) 3
cells (3) 3
chromatography, high pressure liquid - methods (3) 3
chromatography, liquid - methods (3) 3
complications and side effects (3) 3
direct thrombin inhibitor (3) 3
drug administration schedule (3) 3
drug-drug interaction (3) 3
efflux ratio (3) 3
etexilate (3) 3
factor xa inhibitors (3) 3
fondaparinux (3) 3
healthy-subjects (3) 3
hemorrhage - chemically induced (3) 3
inhibitor (3) 3
liquid chromatography (3) 3
meprobamate (3) 3
meta-analysis (3) 3
model (3) 3
oral anticoagulant (3) 3
pharmaceutical sciences (3) 3
pharmacology (3) 3
pharmacy (3) 3
poisoning (3) 3
polysaccharides - pharmacokinetics (3) 3
prediction (3) 3
prospective studies (3) 3
pyrazoles - blood (3) 3
pyridones - blood (3) 3
quantification (3) 3
risk factors (3) 3
rivaroxaban - blood (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Presse Medicale, ISSN 0755-4982, 09/2013, Volume 42, Issue 9, pp. 1206 - 1212
All new oral anticoagulants are direct specific reversible inhibitors, either direct factor Xa inhibitors or inhibitors of thrombin.The pharmacokinetic of the... 
Journal Article
La Presse Medicale, ISSN 0755-4982, 09/2013, Volume 42, Issue 9, pp. 1206 - 1212
The pharmacokinetic of the new drugs is That explains an important risk of drug interactions. no need for laboratory monitoring. . Ces molécules se... 
Journal Article
Presse medicale (Paris, France : 1983), 09/2013, Volume 42, Issue 9 Pt 1, p. 1206
All new oral anticoagulants are direct specific reversible inhibitors, either direct factor Xa inhibitors or inhibitors of thrombin. The pharmacokinetic of the... 
Drug Interactions | Anticoagulants - administration & dosage | Administration, Oral | Humans | Risk Factors | Anticoagulants - physiology
Journal Article
Journal of Drug Delivery Science and Technology, ISSN 1773-2247, 06/2018, Volume 45, p. 159
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.jddst.2018.03.002 The... 
Blood-brain barrier | Carrier proteins | Drug interactions | Observations | Health aspects
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 09/2019, Volume 234, Issue 9, pp. 15438 - 15449
Unfractionated heparin (UFH) and low molecular heparin derivatives (LMWH) display numerous biological properties in addition to their anticoagulant effects.... 
heparin | low molecular heparin derivatives | podocyte permeability | podocyte | Albumin | Anticoagulants (Medicine) | Permeability | Analysis | Cells | Biological properties | Heterogeneity | Anticoagulants | Morphology | Membrane permeability | Cytoskeleton | Extracellular matrix | Heparin | Derivatives | In vitro methods and tests | Heparins
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 07/2017, Volume 56, Issue 7, pp. 793 - 801
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 06/2018, Volume 365, Issue 3, pp. 519 - 525
Direct oral anticoagulants (DOACs) could represent an interesting alternative to conventional anticoagulant treatment with vitamin K antagonists in pulmonary... 
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 05/2013, Volume 78-79, pp. 150 - 153
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 04/2019, Volume 85, Issue 4, pp. 771 - 781
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 05/2018, Volume 102, Issue 5, pp. 692 - 699
AimsTo evaluate the efficacy of a subconjunctival dexamethasone-releasing implant in preventing rejection of penetrating keratoplasty (PK) in an animal... 
dexamethasone | penetrating keratoplasty | subconjunctival implant | immunosuppression | rejection | rabbit | EYE | OPHTHALMOLOGY | ALLOGRAFT-REJECTION | INTRAVITREAL IMPLANT | CORNEAL GRAFT-REJECTION | ENDOTHELIAL KERATOPLASTY | Glaucoma | Rabbits | Diabetic retinopathy | Immunology | Compliance | Transplants & implants | Anesthesia | Ophthalmology | Iodine | Index Medicus
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 02/2014, Volume 111, Issue 2, pp. 240 - 248
While laboratory monitoring is not required in patients treated with apixaban, a direct factor-Xa inhibitor, assessment of its concentration is useful in some... 
anti-Xa | multicenter study | blood coagulation tests | anticoagulant agents | Apixaban | Blood Coagulation, Fibrinolysis and Cellular Haemostasis | HEALTHY-SUBJECTS | SAFETY | THROMBIN | RIVAROXABAN | TIME | COAGULATION ASSAYS | IMPACT | RECOMMENDATIONS | ORAL ANTICOAGULANTS | PERIPHERAL VASCULAR DISEASE | INHIBITOR | HEMATOLOGY
Journal Article
Computational Statistics and Data Analysis, ISSN 0167-9473, 03/2016, Volume 95, pp. 207 - 221
Nonlinear mixed effect models are classical tools to analyze nonlinear longitudinal data in many fields such as population pharmacokinetics. Groups of... 
Nonlinear mixed effect model | SAEM algorithm | Pharmacokinetics | Fused lasso | Group comparison | Algorithms | Methodology | Statistics
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.